Papers - HATAKEYAMA SHINGO
-
Efficacy of valganciclovir prophylaxis in kidney transplant recipients following low-dose rituximab induction therapy: a multicenter retrospective study.
Takehara T, Nishida H, Ichikawa K, Nawano T, Takai S, Fukuhara H, Matsuura T, Maita S, Saito M, Murakami R, Hatakeyama S, Obara W, Saitoh H, Ohyama C, Habuchi T, Watanabe M, Tsuchiya N.
Clin Exp Nephrol. 29 2025.3
-
Penile metastasis from a duodenal gastrointestinal stromal tumor: A rare case report.
Yoneyama F, Okamoto T, Hamaya T, Kodama H, Fujita N, Yamamoto H, Imai A, Hatakeyama S.
2025.2
-
Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.
Hara S, Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group.
32 2025.2
-
Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.
Kikuchi H, Osawa T, Matsushita Y, Kojima T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Ueda K, Tanaka H, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Kato T, Hara H, Ito Y, Kitamura H, Miyake H, Shinohara N
2025.2
-
Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma.
Mori K, Numakura K, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Yamana K, Kandori S, Kimura T, Nishiyama N, Bando Y, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Kitamura H, Miyake H, Habuchi T.
Cancer Sci. 116 2025.2
-
Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone-sensitive prostate cancer: A multicenter study.
Yanagisawa T, Fukuokaya W, Hatakeyama S, Narita S, Muramoto K, Katsumi K, Takahashi H, Urabe F, Mori K, Tashiro K, Iwatani K, Shimomura T, Habuchi T, Kimura T.
Prostate. 85 2025.2
-
特集 今のうちにしっかり理解 最新の前立腺癌診療と近未来予想図 〈治療〉 高リスク前立腺癌に対するネオアジュバント内分泌化学療法を用いた手術療法
米山 高弘, 山本 勇人, 畠山 真吾
臨床泌尿器科 79 ( 1 ) 56 - 62 2025.1
-
特集 今のうちにしっかり理解 最新の前立腺癌診療と近未来予想図 企画にあたって 今のうちにしっかり理解 最新の前立腺癌診療と近未来予想図
畠山 真吾
臨床泌尿器科 79 ( 1 ) 5 - 5 2025.1
-
Prognostic model for second progression-free survival and overall survival in patients with high-risk metastatic hormone-sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy. 🗍
85 73 2025.1
-
Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter study.
🗍� Kato M, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Yamamoto S, Matsue T, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Uchida J; Japan Urological Oncology Group.
Int J Clin Oncol. 2024.12
-
Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer. 🗍
Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T.
31 2024.12
-
Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy
Miura H, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Moriyama S, Oishi T, Horiguchi H, Soma O, Noro D, Tanaka T, Okamoto T, Yamamoto H, Sato S, Ohyama C.
Int J Urol 31 1330-1336 2024.12
-
Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer.
Miura H, Yamamoto H, Okuyama Y, Ishi N, Tanaka R, Oishi T, Yoneyama F, Hamaya T, Togashi K, Fujita N, Okamoto T, Ohyama C, Hatakeyama S
Cancer medicine 13 ( 24 ) e70226 2024.12
-
The first detailed annual record on the National Clinical Database Urology Division in Japan: A report on five surgical procedures.
Kikuchi E, Yamamoto H, Yasui T, Hatakeyama S, Mizuno R, Sakamoto S, Mizuno K, Morizane S, Hayakawa N, Kobayashi T, Kamoto T, Eto M
International journal of urology : official journal of the Japanese Urological Association 31 ( 12 ) 1344 - 1355 2024.12
-
Annual record on the number of general urological surgeries registered in the National Clinical Database system between April 2018 and December 2021 in Japan
Yasui T, Kikuchi E, Yamamoto H, Ishii D, Mizuno R, Hatakeyama S, Kobayashi T, Uchida J, Takahashi M, Sakamoto S, Morizane S, Kamoto T, Eto M.
Int J Urol. 31 1256-1262 2024.11
-
Clinical significance of PSA dynamics in castration-sensitive prostate cancer treated with ARSI doublet therapy: A multicenter study.
Urabe F, Hatakeyama S, Yanagisawa T, Narita S, Muramoto K, Katsumi K, Takahashi H, Fukuokaya W, Mori K, Tashiro K, Iwatani K, Shimomura T, Miki J, Habuchi T, Kimura T; JHA Collaborative Group.
Urol Oncol 2024.10
-
Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study
Miki J, Fukuokaya W, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group.
31 ( 9 ) 1009-1016. 2024.9
-
Long-Term Outcomes of Orthotopic Neobladder Versus Ileal Conduit Urinary Diversion in Robot-Assisted Radical Cystectomy (RARC): Multicenter Results from the Asian RARC Consortium.
31 2024.9
-
Pre-Op Hydronephrosis Predicts Outcomes in Patients Receiving Robot-Assisted Radical Cystectomy. 🗍
Wong CH, Ko IC, Leung DK, Kang SH, Kitamura K, Horie S, Muto S, Ohyama C, Hatakeyama S, Patel M, Yang CK, Kijvikai K, Lee JY, Chen HG, Zhang RY, Lin TX, Lee LS, Teoh JY, Chan E.
16 2826 2024.8
-
Prognostic impact of histological discordance between transurethral resection and radical cystectomy
Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y; Japanese Urological Oncology Group.
BJU Int 134 ( 2 ) 207-218 2024.8